本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NEWAMSTERDAM PHARMA CO NV

19.13
+0.58003.13%
盘前19.590.4600+2.40%07:19 EDT
成交量:86.44万
成交额:1,673.51万
市值:21.01亿
市盈率:-7.47
高:19.98
开:18.40
低:17.77
收:18.55
数据加载中...
2025/04/17

重要事件披露

Form 8-K - Current report
2025/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

SEC问询函

Form CORRESP - Correspondence
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/13

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/11/20

重要事件披露

Form 8-K - Current report